Titre :
  • Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
Auteur : Leboulleux, Sophie ; Bastholt, Lars ; Krause, Thomas ; de la Fouchardiere, Christelle ; Tennvall, Jan ; Awada, Ahmad ; Gómez, José Manuel ; Bonichon, F. ; Leenhardt, Laurence ; Soufflet, Christine ; Licour, Muriel ; Schlumberger, Martin Jean
Informations sur la publication : Lancet oncology, 13, 9, (page 897-905)
Statut de publication : Publié, 2012-09
Sujet CREF : Cancérologie
Mots-clés MeSH : Adenocarcinoma, Follicular
Adolescent
Adult
Aged
Antineoplastic Agents -- therapeutic use
Bone Neoplasms -- secondary
Carcinoma
Diarrhea -- chemically induced
Disease-Free Survival
Double-Blind Method
Electrocardiography -- drug effects
Female
Heart Conduction System -- drug effects
Humans
Kaplan-Meier Estimate
Lung Neoplasms -- secondary
Lymphatic Metastasis
Male
Middle Aged
Piperidines -- adverse effects -- therapeutic use
Quinazolines -- adverse effects -- therapeutic use
Receptor, Epidermal Growth Factor -- antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
Skin Neoplasms -- secondary
Survival Analysis
Thyroid Neoplasms -- drug therapy -- mortality -- pathology -- secondary
Young Adult
Note : Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:1470-2045 
info:doi/10.1016/S1470-2045(12)70335-2
info:pii/S1470-2045(12)70335-2
info:pmid/22898678